Abstract
Retinitis pigmentosa (RP), a neurodegenerative disorder, can arise from single point mutations in rhodopsin, leading to a cascade of protein instability, misfolding, aggregation, rod cell death, retinal degeneration, and ultimately blindness. Divalent cations, such as zinc and copper, have allosteric effects on misfolded aggregates of comparable neurodegenerative disorders including Alzheimer disease, prion diseases, and ALS. We report that two structurally conserved low-affinity zinc coordination motifs, located among a cluster of RP mutations in the intradiscal loop region, mediate dose-dependent rhodopsin destabilization. Disruption of native interactions involving histidines 100 and 195, through site-directed mutagenesis or exogenous zinc coordination, results in significant loss of receptor stability. Furthermore, chelation with EDTA stabilizes the structure of both wild type rhodopsin and the most prevalent rhodopsin RP mutation, P23H. These interactions suggest that homeostatic regulation of trace metal concentrations in the rod outer segment of the retina may be important both physiologically and for an important cluster of RP mutations. Furthermore, with a growing awareness of allosteric zinc binding domains on a diverse range of GPCRs, such principles may apply to many other receptors and their associated diseases.
Protein misfolding and aggregation is a shared etiology among many neurodegenerative disorders, including Alzheimer disease, Parkinson disease, familial amyotrophic lateral sclerosis, and transmissible spongiform encephalopathies. Over 100 distinct inherited mutations have been identified in rhodopsin, predominantly resulting in misfolding, aggregation, and cell death, followed by clinical manifestation of the retinal neurodegenerative disorder Retinitis Pigmentosa (RP) [1]. Increasing evidence has demonstrated that biologically important and ubiquitous metals, zinc (Zn2+) and copper (Cu2+), directly bind to the β-amyloid (Alzheimer disease) and prion (transmissible spongiform encephalopathies) proteins, linking the gain of non-native, low-affinity metal binding to progression of these disorders. Moreover, Zn2+ promotes aggregation of the highly fibrillogenic prion peptide, PrP106-126 [2] and of β-amyloid [3–5]. Such findings have led to promising clinical investigation of metal protein attenuating compounds, based on clioquinol, as potential therapeutics to mitigate β-amyloid neurotoxicity [6–8].
Numerous studies have identified Zn2+ as an allosteric modulator of several GPCRs [9–16], including localization of Zn2+ coordination sites to extracellular loops of melanocortin [13, 14], chemokine [15], olfactory [16], and tachykinin [12] receptors. These receptors are located within the central nervous system (CNS), where zinc is predominantly stored in synaptic vesicles as a modulator of neuronal excitability [17], and can be found with acute concentrations exceeding 300 µM [18, 19], suggesting that Zn2+ coordination may represent a conserved mechanism regulating GPCRs in the CNS. In a recent study, we identified an essential high-affinity Zn2+ coordination site in the transmembrane domain of rhodopsin [20]. Interestingly, we also identified a low-affinity zinc-associated component that significantly destabilized rhodopsin, an effect specific to zinc and copper [21]. Molecular modeling of the rhodopsin crystal structure, in conjunction with data from our previous study [20], indicate His100 and His195 in the intradiscal domain of rhodopsin as primary candidates for this Zn2+-mediated effect.
The intradiscal domain of rhodopsin, corresponding to the extracellular domain of related GPCRs, is composed of the N-terminus region (residues 1–33), loop II–III (101–105), loop IV–V (173–198), and loop VI–VII (277–285). Mutations in this region prevent rhodopsin from folding properly in vitro, a property which precipitates aggregation in the endoplasmic reticulum (ER) [22, 23] and subsequent degradation by retinal pigment epithelial cells in vivo. The N-terminus tail plays an important role in rhodopsin folding and trafficking [24, 25], while loop IV–V (173–198) contains Cys187, which forms a highly conserved disulfide bond with Cys110 [26, 27]. This disulfide linkage is essential for proper folding, stability, and function of rhodopsin [26, 28–30]. Interestingly, a cluster of RP mutations occurs in this region, many of which promote formation of alternate disulfide bonding [29]. RP mutations Cys110Ala, Cys110Phe, and Cys110Tyr all form an alternate Cys185-Cys187 disulfide bond, lacking 11-cis-retinal binding [27, 29]. Additionally, formation of an ion pair between Arg177 and Asp190 located at the ends of the second extracellular loop is critical for folding and stability of dark state rhodopsin [31].
In this study, our goal was to identify and characterize the low-affinity metal coordination sites mediating destabilization, and determine potential influence of this phenomenon on normal and pathological RP rhodopsin. We report that two structural networks in the intradiscal domain surrounding His100 and His195 are susceptible to pathophysiological changes in trace metal concentrations. Trace metal chelation assisted in stabilizing the most common form of RP mutations Pro23His demonstrating such modality as a possible avenue for therapy in select RP mutations.
EXPERIMENTAL PROCEDURES
Site Directed Mutagenesis and Preparation of Rhodopsin Protein Samples
Amino acid substitutions were introduced into the synthetic rhodopsin gene through PCR mutagenesis, as previously described [32]. For single mutants, a synthetic wild-type rhodopsin gene was used as the template [32]. For the His100Phe/His195Phe double mutant, the His195Phe mutant was synthesized using PCR mutagenesis, followed by mutagenesis of His100Phe using His195Phe as the template. COS-1 cells were transfected with pMT4 vectors carrying the opsin genes. Cells were harvested, opsins regenerated with 11-cis-retinal, and rhodopsin proteins purified by immunoaffinity chromatography as previously described [32]. Rhodopsin concentration was determined through UV-Vis spectroscopy (500 nm absorbance) [32].
UV-Visible (UV-Vis) Absorption Spectroscopy
UV-Vis absorption spectra were recorded on a Perkin-Elmer λ-40 UV-Vis spectrophotometer at 2°C, 10°C, or 25°C [32]. Rhodopsin thermal stability was determined by monitoring the decay of the 500 nm absorbance at a constant temperature of 50°C, unless otherwise noted. Protein samples were allowed to equilibrate (approximately 2 minutes) to 50°C prior to acquiring absorption spectra. Absorption spectra were obtained at 5-minute intervals until the 500 nm absorbance decreased to background levels. Initial values of the 500 nm absorbance were normalized between experiments to account for baseline shifts and differences in sample protein concentrations (approximately 1.3 µM).
Computer Modeling
The rhodopsin crystal structures (PDB ID: 1L9H [33] and 1U19 [34]) were visualized with Swiss PDB Viewer (GlaxoSmithKline, Geneva, Switzerland) [35], with some images generated using WebLab Viewer Pro 3.2 (Molecular Simulations, Inc. San Diego, CA). In some models, as described, particular residues were altered from their crystallized structure to propose alternate interactions.
Data Analysis
Values for all experiments are expressed as mean ± SEM. All means and SEM were calculated from at least three distinct experiments using separate protein preparations. Exponential decay rate constants (k) and half-lives were derived through nonlinear regression using GraphPad Prism® software. A 95% confidence interval was used for all curve-fitting procedures using GraphPad Prism. Where applicable, statistical significance of the data was evaluated using an ANOVA and/or unpaired t test (*, p<.05; **, p<0.01; ***, p<0.001).
RESULTS
Wild-type rhodopsin becomes less thermostable in the presence of exogenous zinc (Figure 1A). Chelative treatment with 1 mM EDTA stabilized the wild-type rhodopsin receptor (Figure 1A). In a recent study, using inductively coupled plasma mass spectrometry (ICP-MS), we quantified 1.33 ± 0.27 Zn2+ ions per molecule of rhodopsin under 10 µM treatment conditions [20]. This suggested the presence of other lower affinity sites, in addition to the single high affinity transmembrane site identified [20]. Moreover, despite the use of approximately 100 mM zinc in the crystallization procedure, the presence of additional sites are supported by rhodopsin’s crystal structure [33, 36, 37]. To confirm that other physiologically relevant sites are present, we performed a zinc dose response (thermostability) and calculated the zinc log(EC50) for the alternative site/s to be 1.76 ± 0.08 (log[Zn2+] µM), corresponding to an EC50 of 57.1 µM (Figure 1B), confirming both specificity, and the low affinity nature for these additional zinc binding sites. This is consistent with previous findings, and supports the identification of greater than one zinc per rhodopsin molecule detected using ICP–MS [20]. A pH profile for thermostability confirmed a pKA of ~6.7, supporting the possible involvement of His in zinc coordination (Figure 1C). Our goals were then to precisely identify the site/s, determine mechanism for their actions, and determine whether they may be relevant to Retinitis Pigmentosa rhodopsin mutations.
Analysis of the Rhodopsin Crystal Structure Indicates His100 and His195 as Potential Sites of Zn2+ Coordination
From the four sites depicting Zn2+ coordination in the crystal structure [33], combined with our previous data [20], the sites containing histidine residues His100 and His195 provide the only suitable candidates for Zn2+ coordination. The lack of a histidine, cysteine, or aspartic acid residue at one of the potential Zn2+ binding sites, predicted to be formed by Glu201 and Gln279, suggests this site to be artifactual (Figure 2A). Based on our pH-profile analysis of receptor stability and zinc-destabilization, histidines are critical to the zinc response. The two remaining sites (Figures 2B and 2C) each contain a histidine residue (His100 and His195, respectively). In the rhodopsin crystal structure, one Zn2+ ion is located at the dimeric interface between the two rhodopsin monomers, coordinated by Tyr96 and His100 (from one monomer “a”), Lys311 and a backbone amine group from the peptide bond between Gly329 and Asp330 (from the second monomer “b”; Figure 2B). As tyrosine and lysine are inadequate for zinc coordination, attention focused on the corresponding histidine (His100) in the intradiscal domain of rhodopsin. Additionally, His100 is in proximity of other polar residues, allowing for alternate interactions conceivably masked by the presence of zinc. As such, both His100 and His195 were suitable candidates for further analysis.
We based our evaluation of the intradiscal hydrogen bonding network on the 1L9H and 1U19 rhodopsin structures. Of the other available rhodopsin crystal structures (PDB: 1F88, 1HZX, 1GZM, 3C9L, and 3C9M), evaluations of 1HZX and 3C9L were included in our initial assessment, and deemed suitably consistent to continue with our current working model. Our focus on the Okada rhodopsin structures, despite the availability of additional structures, was based on the other published structures having removed divalent cations in post-processing, leaving manually inserted water molecules in their place. The substantial resolution of the structures by Okada et al. strengthened and supported our decision.
His100 mediates the destabilization conferred by trace metals
Of the 102 sequenced vertebrate type I opsin proteins (GPCRdb [38]), His100 is highly conserved, present in 79% of the sequences (Figure 3A), followed by asparagines (19%). Histidine and asparagine, each possess a protonatable nitrogen at the delta position. Interestingly, the remaining 2% of sequences contain nitrogen at the epsilon position, suggesting complete conservation of this functional group among vertebrate type I opsins. We initially performed site-directed mutagenesis of His100 to a similarly sized phenylalanine, lacking the polarity to coordinate Zn2+, or to form hydrogen bonds. There was no significant difference in the ability of His100Phe rhodopsin to bind 11-cis-retinal at 25°C, as the A280/A500 ratio and absorbance maxima of 2.0 similar to wild-type (WT) (Supplement Figure 2). When we treated wild-type rhodopsin with 50 µM ZnCl2 (EC50 concentration), rhodopsin decayed at an increased rate of 0.044 ± 0.002 min−1 (WT = 0.026 ± 0.002 min−1, a ratio of 1.69, p<0.001; Figure 3C). The k rate constant of rhodopsin decay also increased from 0.026 ± 0.002 min−1 for wild-type rhodopsin to 0.057 ± 0.005 min−1 for His100Phe (H100F) (a ratio of 2.19, p<0.001). Additionally, comparing the H100-related decay curves with a two-way ANOVA confirms their significance (p<0.001). These data indicate that disruption of His100-mediated interactions, through site-directed mutagenesis, results in rhodopsin destabilization similar to Zn2+ treatment. Treating His100Phe with 50 µM ZnCl2, led to further destabilization, decaying at an accelerated rate of 0.084 ± 0.009 min−1, compared to the initial rate of 0.057 ± 0.005 min−1 for His100Phe alone (a ratio of 1.47, p<0.05). The similar level of destabilization between His100Phe and wild-type treated with zinc supports the notion of His100 involvement; however, additional loss of receptor thermostability with post-mutational addition of zinc suggests that either an additional or alternative site is directly involved in the observed zinc-mediated destabilization.
Crystal Structure Analysis Indicates the Presence of a Highly Conserved Hydrogen-Bonding Network Coordinated by His100
Disrupting the receptor structure with zinc or mutagenesis, at position 100, impairs receptor stability, suggesting important native interactions with proximal amino acids. We identified Tyr96 (100% conserved in transmembrane domain II) and Tyr102 (93% conserved in extracellular loop II) as likely candidates (Figure 3B). A Tyr-His-Tyr triad appears in 79% of the vertebrate opsins and in each opsin containing a His100 residue, with tyrosine 96 having 93% conservation and tyrosine 102 completely conserved (Figure 3A). Extending this evaluation beyond simple sequence conservation to the relative position of functional groups supports the hypothesis of regional structural preservation. Threonine has 88% conservation at position 97, with the remaining sequences possessing serine at this site, resulting in 100% conservation of the gamma-hydroxyl functional group. Interestingly, position 101 maintains 100% conservation of small flexible Gly or Ala residues.
His195 additionally mediates trace metal regulated thermostability
Further receptor destabilization with addition of zinc to His100Phe suggests that another site also contributes to the effect. An alternative extracellular histidine (His195) was similarly characterized using site-directed mutagenesis and thermal stability assessment. In contrast to His100, His195 is unique to bovine rhodopsin (the source of the crystal structure), with a lysine residue at this position in human rhodopsin. Lysine is 42% conserved at position 195 across type I vertebrate opsins, second only to alanine (44%) (Figure 4A). His195Phe and His195Lys showed no significant difference in the ability to bind 11-cis-retinal at 25°C, with an absorbance ratio similar to wild-type (WT). Both His195Phe and His195Lys mutations destabilized rhodopsin less dramatically than mutation of His100. Interestingly, while His195Lys was less stable than WT, this mutation also reduced the destabilizing impact of zinc treatment. The k rate constant of rhodopsin decay increased from the wild-type (0.026 ± 0.002 min−1) to 0.037 ± 0.005 min−1 for His195Lys and 0.069 ± 0.005 min−1 (a ratio of 2.65, p<0.0001) for His195Phe (Figure 4C). As before, comparing the collection of decay curves using a two-way ANOVA confirms their significance (p<0.001), and suggest that, as with His100, disruption of His195 also mediates the destabilizing effects observed with ZnCl2 treatment. To evaluate involvement of His195 in metal coordination, we treated these two rhodopsin mutants (His195Phe and His195Lys) with ZnCl2. Both mutants demonstrated elevated destabilization with Zn2+ treatment, though this effect was modest for His195Lys. The His195Lys mutant, decayed at a rate of 0.037 ± 0.005 min−1, with an increased rate of 0.042 ± 0.003 min−1 upon addition of 50 µM ZnCl2. The His195Phe mutant decayed at a rate of 0.069 ± 0.005 min−1, compared to an accelerated rate of 0.087 ± 0.005 min−1 (a ratio of 1.26, p<0.05) when treated with 50 µM ZnCl2. Not surprisingly, His195Lys remains a great deal more stable than His195Phe, as it retains similar polarity to the native bovine rhodopsin histidine, again highlighting important intradiscal interactions involving the residue at this position. Interestingly, the observed differences between His195 and His195Lys suggest that, while Lys195 is less stable than His195, it may provide some degree of protection from additional structural instability induced by zinc association.
Opsin Sequence Analysis Supports the Presence of a Conserved Interaction between Residues 195 and 197
Sequence analysis indicates the His195-Glu197 pair to be unique to bovine rhodopsin, however a Lys195-Glu197 pair is 32% conserved across the vertebrate opsins including human rhodopsin (Figure 4A). Beginning at residue 194, a motif of LKPEV accounts for 31% of all type I vertebrate opsins with RAEGF accounting for 35%. Taken together, a motif of (R194/K195)xE is 82% conserved. Phylogenic distribution of these structural motifs, among type I vertebrate opsins, reveals segregation between land (LKPEV dominant) and aquatic (RAEGF dominant) vertebrates. Modeling illustrates that the LKPEV motif maintains a pocket capable of accommodating zinc-coordination, whereas the RAEGF motif may not (Figure 4B). Bovine rhodopsin is unique at this position, containing a PHEET motif. Furthermore, our study suggests that disrupting this interaction, through site-directed mutagenesis or zinc coordination, alters the structure of this region resulting in dramatic protein instability. This instability may very occur through subsequent disruption of the proposed ion pair between Arg177 and Asp190 (Figure 4A and 4B) located at the ends of the second extracellular loop which is critical for folding and stability of dark state rhodopsin [31].
The His100Phe/His195Phe Double-Mutant is unaffected by further zinc treatment
To evaluate whether these histidines are sufficient to mediate the observed Zn2+-induced instability, we constructed the His100Phe/His195Phe double-mutant rhodopsin protein. The His100Phe/His195Phe mutant displayed reduced 11-cis-retinal binding at 25°C. Thermal stability of the His100Phe/His195Phe double-mutant (Figure 5), with an accelerated decay rate of 0.277 ± 0.027 min−1 , demonstrated dramatic impact on protein stability relative to wild-type rhodopsin (0.026 ± 0.002 min−1) (a ratio of 10.65, p<0.0001),. The resulting instability appears to be synergistic, as each individual mutation accounts for less than half the observed decay rate (His100Phe at 0.057 ± 0.005 min−1 and His195Phe at 0.069 ± 0.005 min−1). There was no statistically significant difference between the His100Phe/His195Phe double-mutant treated with 50 µM ZnCl2 that decayed at a rate of 0.225 ± 0.023 min−1 and the untreated double-mutant, which decayed at a rate of 0.277 ± 0.027 min−1 (p>0.05; ns; Figure 5A), supporting the identification of the critical zinc coordination sites. Further studies were performed at 37°C to assess whether there were any significant differences at a lower temperature where rhodopsin would be more stable (Figure 5B). As expected the double mutant receptor demonstrated increased stability at 37°C (0.144 ± 0.017 min−1) compared to 50°C. Consistent with the higher temperature experiments, the addition of 50 µM Zn2+ (0.165 ± 0.015 min−1) or 1 mM EDTA (0.155 ± 0.016 min−1) made no further impact on the double mutant. These results support both His100 and His195 as critical rhodopsin stabilizing sites which are exquisitely sensitive to destabilization by zinc coordination.
Chelation of trace Zn2+ can stabilize Retinitis Pigmentosa mutation Pro23His
As exogenous zinc demonstrated a physiological role in modulating rhodopsin structural stability, we hypothesized that it may additionally play a role for structurally impaired RP mutants. Wild-type rhodopsin treated with EDTA showed significant thermal stabilization (Figure 1A). The Pro23His rhodopsin mutation (most common RP mutations in North America) results in a structure significantly less stable than WT rhodopsin, with a decay rate of 0.450 ± 0.032 min−1. Pre-treatment of Pro23His rhodopsin with 1 mM EDTA significantly increases receptor thermostability (0.173 ± 0.021 min−1) at high temperature (a ratio of 2.60, p<0.05; Figure 6A). Although this corresponds to greater than a two-fold increase in receptor half-life, the rapidity of receptor unfolding at this high temperature results in a low resolution of decay rates for highly unstable forms of rhodopsin like Pro23His. To increase resolution of this observation, a lower temperature (37°C) demonstrates enhanced stability, with a decay rate of 0.122 ± 0.012 for Pro23His, increasing to 0.027 ± 0.007 with 1 mM EDTA treatment (a ratio of 4.52, p<0.05; Figure 6B). This difference corresponds to more than a four-fold increase in receptor half-life. We hypothesize that as with wild type, EDTA chelation stabilizes the Pro23His through prevention of zinc coordination at the native His100, His195Phe sites. We cannot exclude the formation of a third zinc binding site involving Pro23His, though we surmise that zinc can similarly influence intradiscal RP mutations and may therefore play a role in disease progression and therapy.
DISCUSSION
Allosteric effects of trace metals on G-protein coupled receptors have demonstrated implications in both health and disease [9–16, 39, 40]. Trace metals such as zinc can accumulate to high concentrations within organs and subcellular compartments [41], influencing many neurodegenerative diseases [2–4, 41, 42]. The rhodopsin crystal structure provides a unique opportunity to elucidate precise mechanisms of allosteric action. This ultimately can serve to establish important principles for other GPCRs.
Zinc binding has dual and opposing roles
Rhodopsin displays differential responses to zinc: Transmembrane coordination helps stabilize the receptor [20] and intradiscal coordination appears to destabilize purified rhodopsin (current study). Dual zinc association (His100 and His195) within the intradiscal region mediates disruption of receptor thermostability through low-affinity histidine coordination. Significant conservation surrounds the His100 zinc-coordinating region, in contrast to His195, which is unique to bovine rhodopsin. Simultaneous replacement of these groups with phenylalanine results in severe structural impairment and eliminates further metal-induced destabilization. Interestingly, human Lys195 appears to assist structural integrity in this region, reducing wild type rhodopsin susceptibility to metal interference in comparison to bovine rhodopsin.
With sensitivity to zinc in the physiological range (as observed from our dose response) and evidence of a gradient free zinc distribution within the rod cell itself (high ER concentrations, low in outer segment, and very high in the RPE) [43], we speculate that the observed destabilization may serve both physiological and pathological roles. The high zinc concentrations around the ER may be involved in rhodopsin folding (or dimerization as proposed by Park et al [44]), particularly with the assistance of chaperonins. The absence of available free zinc across the outer segment (as with our EDTA experiments) imposes maximal stability and thus optimal rhodopsin function. Finally, high zinc concentrations observed in the RPE may assist in the destabilizing, unfolding, and proteolytic degradation of rhodopsin. In the absence of chaperonins or proteolytic cleavage, instability arising from zinc coordination may promote oligomerization and/or aggregation. Formation of stable oligomers is supported by previous scanning force microscopy (SFM) data suggesting that zinc-coordination promotes self-association of the photoreceptor [44].
Implications for Retinitis Pigmentosa
Our findings with the most prevalent rhodopsin RP mutation, Pro23His, support a potential pathological involvement of zinc-coordination in rhodopsin. In the context of retinitis pigmentosa, the impairment of receptor integrity observed with trace metal coordination would accelerate the progression of disease. Specific RP mutations, particularly those among the intradiscal region, may amplify the impact of metal-induced destabilization. The instability of Pro23His may be related to potential aberrant Zn-binding sites, or influence the known sites, in addition to effects on the native disulfide bond. Unfortunately, misfolding and aggregation currently prevents accurate assessments of these possibilities. Although chelative zinc removal does not completely restore the P23H photoreceptor to wild-type stability levels, half-life increases of three-fold to five-fold may be suitable to slow the progression of retinal degeneration. The impact of structural impairment in RP progression, coupled with metal-induced misfolding, permits speculation regarding the possibility for chelative agents to inhibit disease progression. Metal protein attenuating compounds, such as PBT2 [45], are being developed and evaluated for utility in chelating metals from protein aggregates. Though currently focused on Alzheimers plaques, if analogs can distribute, or be delivered, to photoreceptors they may be useful in a subset of RP mutants. The influence of metal-coordination on rhodopsin structural integrity extends insight into native receptor structure, enhancing general understanding of GPCRs, and may point toward potential therapeutics.
Supplementary Material
Abbreviations
- A500
absorbance at 500nm
- ANOVA
analysis of variance
- ED50
half maximal effective dose
- EDTA
ethylenediaminetetraacetic acid
- GPCR
G-protein coupled receptor
- His
histidine
- ICP-MS
inductively coupled plasma mass spectrometry
- Lys
lysine
- Phe
phenylalanine
- pKa
acid dissociation constant
- Pro
proline
- RP
Retinitis Pigmentosa
- SDS
sodium dodecyl sulfate
- SEM
standard error of the mean
- SFM
scanning force microscopy
- Tyr
tyrosine
- UV-Vis
ultraviolet-visible
- WT
wild-type
- Zn
zinc
Footnotes
Funding Provided by NIH NHLBI RO1 HL074190-01 and The Karl Kirchgessner Foundation Research Grant
References
- 1.Stojanovic A, Hwa J. Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Receptors Channels. 2002;8(1):33–50. [PubMed] [Google Scholar]
- 2.Jobling MF, et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry. 2001;40(27):8073–8084. doi: 10.1021/bi0029088. [DOI] [PubMed] [Google Scholar]
- 3.Atwood CS, et al. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998;273(21):12817–12826. doi: 10.1074/jbc.273.21.12817. [DOI] [PubMed] [Google Scholar]
- 4.Huang X, et al. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J Biol Chem. 1997;272(42):26464–26470. doi: 10.1074/jbc.272.42.26464. [DOI] [PubMed] [Google Scholar]
- 5.Lynch T, Cherny RA, Bush AI. Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions. Exp Gerontol. 2000;35(4):445–451. doi: 10.1016/s0531-5565(00)00112-1. [DOI] [PubMed] [Google Scholar]
- 6.Doraiswamy PM, Xiong GL. Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opinion on Pharmacotherapy. 2006;7(1):1–10. doi: 10.1517/14656566.7.1.1. [DOI] [PubMed] [Google Scholar]
- 7.Ritchie CW, Bush AI, Masters CL. Metal-protein attenuating compounds and Alzheimer's disease. Expert Opinion on Investigational Drugs. 2004;13(12):1585–1592. doi: 10.1517/13543784.13.12.1585. [DOI] [PubMed] [Google Scholar]
- 8.Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc. 2003;51(8):1143–1148. doi: 10.1046/j.1532-5415.2003.51368.x. [DOI] [PubMed] [Google Scholar]
- 9.Schetz JA, Sibley DR. Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors. J Neurochem. 1997;68(5):1990–1997. doi: 10.1046/j.1471-4159.1997.68051990.x. [DOI] [PubMed] [Google Scholar]
- 10.Swaminath G, Lee TW, Kobilka B. Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor. J Biol Chem. 2003;278(1):352–356. doi: 10.1074/jbc.M206424200. [DOI] [PubMed] [Google Scholar]
- 11.Swaminath G, et al. Allosteric modulation of beta2-adrenergic receptor by Zn(2+) Mol Pharmacol. 2002;61(1):65–72. doi: 10.1124/mol.61.1.65. [DOI] [PubMed] [Google Scholar]
- 12.Rosenkilde MM, et al. Natural agonist enhancing bis-His zinc-site in transmembrane segment V of the tachykinin NK3 receptor. FEBS Lett. 1998;439(1–2):35–40. doi: 10.1016/s0014-5793(98)01331-3. [DOI] [PubMed] [Google Scholar]
- 13.Holst B, Elling CE, Schwartz TW. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J Biol Chem. 2002;277(49):47662–47670. doi: 10.1074/jbc.M202103200. [DOI] [PubMed] [Google Scholar]
- 14.Holst B, Schwartz TW. Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann N Y Acad Sci. 2003;994:1–11. doi: 10.1111/j.1749-6632.2003.tb03156.x. [DOI] [PubMed] [Google Scholar]
- 15.Gerlach LO, et al. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor. Biochemistry. 2003;42(3):710–717. doi: 10.1021/bi0264770. [DOI] [PubMed] [Google Scholar]
- 16.Wang J, Luthey-Schulten ZA, Suslick KS. Is the olfactory receptor a metalloprotein? Proc Natl Acad Sci U S A. 2003;100(6):3035–3039. doi: 10.1073/pnas.262792899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Frederickson CJ, et al. Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron. J. Nutr. 2000;130(5):1471S–1483S. doi: 10.1093/jn/130.5.1471S. [DOI] [PubMed] [Google Scholar]
- 18.Howell GA, Welch MG, Frederickson CJ. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature. 1984;308(5961):736–738. doi: 10.1038/308736a0. [DOI] [PubMed] [Google Scholar]
- 19.Assaf SY, Chung S-H. Release of endogenous Zn2+ from brain tissue during activity. Nature. 1984;308(5961):734–736. doi: 10.1038/308734a0. [DOI] [PubMed] [Google Scholar]
- 20.Stojanovic A, Stitham J, Hwa J. Critical role of transmembrane segment zinc binding in the structure and function of rhodopsin. J Biol Chem. 2004;279(34):35932–35941. doi: 10.1074/jbc.M403821200. [DOI] [PubMed] [Google Scholar]
- 21.del Valle LJ, et al. Zinc-induced Decrease of the Thermal Stability and Regeneration of Rhodopsin. J. Biol. Chem. 2003;278(7):4719–4724. doi: 10.1074/jbc.M210760200. [DOI] [PubMed] [Google Scholar]
- 22.Sung CH, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991;88(15):6481–6485. doi: 10.1073/pnas.88.15.6481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Olsson JE, et al. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron. 1992;9(5):815–830. doi: 10.1016/0896-6273(92)90236-7. [DOI] [PubMed] [Google Scholar]
- 24.Borjigin J, Nathans J. Insertional mutagenesis as a probe of rhodopsin's topography, stability, and activity. J Biol Chem. 1994;269(20):14715–14722. [PubMed] [Google Scholar]
- 25.Doi T, Molday RS, Khorana HG. Role of the intradiscal domain in rhodopsin assembly and function. Proc Natl Acad Sci U S A. 1990;87(13):4991–4995. doi: 10.1073/pnas.87.13.4991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Karnik SS, Khorana HG. Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187. J Biol Chem. 1990;265(29):17520–17524. [PubMed] [Google Scholar]
- 27.Hwa J, Klein-Seetharaman J, Khorana HG. Structure and function in rhodopsin: Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants. Proc Natl Acad Sci U S A. 2001;98(9):4872–4876. doi: 10.1073/pnas.061632798. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Karnik SS, et al. Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc Natl Acad Sci U S A. 1988;85(22):8459–8463. doi: 10.1073/pnas.85.22.8459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hwa J, et al. Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function. Proc Natl Acad Sci U S A. 1999;96(5):1932–1935. doi: 10.1073/pnas.96.5.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Davidson FF, Loewen PC, Khorana HG. Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. Proc Natl Acad Sci U S A. 1994;91(9):4029–4033. doi: 10.1073/pnas.91.9.4029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Janz JM, Fay JF, Farrens DL. Stability of Dark State Rhodopsin Is Mediated by a Conserved Ion Pair in Intradiscal Loop E-2. J. Biol. Chem. 2003;278(19):16982–16991. doi: 10.1074/jbc.M210567200. [DOI] [PubMed] [Google Scholar]
- 32.Stojanovic A, et al. Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem. 2003;278(40):39020–39028. doi: 10.1074/jbc.M303625200. [DOI] [PubMed] [Google Scholar]
- 33.Okada T, et al. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A. 2002;99(9):5982–5987. doi: 10.1073/pnas.082666399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Okada T, et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. J Mol Biol. 2004;342:571–583. doi: 10.1016/j.jmb.2004.07.044. [DOI] [PubMed] [Google Scholar]
- 35.Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714–2723. doi: 10.1002/elps.1150181505. [DOI] [PubMed] [Google Scholar]
- 36.Palczewski K, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000;289(5480):739–745. doi: 10.1126/science.289.5480.739. [DOI] [PubMed] [Google Scholar]
- 37.Teller DC, et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of g-protein-coupled receptors (gpcrs)(,) Biochemistry. 2001;40(26):7761–7772. doi: 10.1021/bi0155091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Horn F, et al. GPCRDB information system for G protein-coupled receptors. Nucl. Acids Res. 2003;31(1):294–297. doi: 10.1093/nar/gkg103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Liu Y, et al. Identification of a Zn2+-binding site on the dopamine D2 receptor. Biochemical and Biophysical Research Communications. 2006;339(3):873–879. doi: 10.1016/j.bbrc.2005.11.110. [DOI] [PubMed] [Google Scholar]
- 40.Schetz JA, Chu A, Sibley DR. Zinc Modulates Antagonist Interactions with D2-Like Dopamine Receptors through Distinct Molecular Mechanisms. J Pharmacol Exp Ther. 1999;289(2):956–964. [PubMed] [Google Scholar]
- 41.Frederickson CJ, Koh J-Y, Bush AI. The neurobiology of zinc in health and disease. 2005;6(6):449–462. doi: 10.1038/nrn1671. [DOI] [PubMed] [Google Scholar]
- 42.Cherny RA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits b-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001;30:665–676. doi: 10.1016/s0896-6273(01)00317-8. [DOI] [PubMed] [Google Scholar]
- 43.Akagi T, et al. Differential Subcellular Localization of Zinc in the Rat Retina. J. Histochem. Cytochem. 2001;49(1):87–96. doi: 10.1177/002215540104900109. [DOI] [PubMed] [Google Scholar]
- 44.Park PS-H. Stabilizing Effect of Zn2+ in Native Bovine Rhodopsin. J. Biol. Chem. 2007;282(15):11377–11385. doi: 10.1074/jbc.M610341200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Adlard PA, et al. Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta] Neuron. 2008;59(1):43–55. doi: 10.1016/j.neuron.2008.06.018. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.